Orange Book product · Brand (NDA)
INTRALIPID 30%
SOYBEAN OIL
At a glance
Dec 30, 1993
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 30, 1993
32 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
SOYBEAN OIL
Strength
30%
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 019942
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1998LIPOSYN III 30%Brand (NDA)
NDA 020181 · HOSPIRA
- 1996INTRALIPID 20%Brand (NDA)
NDA 020248 · FRESENIUS
- 1993NUTRILIPID 10%Brand (NDA)
NDA 019531 · B BRAUN
- 1984LIPOSYN III 20%Brand (NDA)
NDA 018970 · HOSPIRA
- 1984LIPOSYN III 10%Brand (NDA)
NDA 018969 · HOSPIRA
- 1983SOYACAL 10%Brand (NDA)
NDA 018465 · ALPHA THERA
- 1983SOYACAL 20%Brand (NDA)
NDA 018786 · ALPHA THERA
- 1983TRAVAMULSION 20%Brand (NDA)
NDA 018758 · BAXTER HLTHCARE
- 1982TRAVAMULSION 10%Brand (NDA)
NDA 018660 · BAXTER HLTHCARE
- —INTRALIPID 10%Brand (NDA)
NDA 017643 · FRESENIUS
- —INTRALIPID 20%Brand (NDA)
NDA 018449 · FRESENIUS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
